Kwabena Kyei-Owusu

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Early-life carriage and antibiotic resistance of Streptococcus pneumoniae in infants from Sierra Leone.

Early-life carriage and antibiotic resistance of Streptococcus pneumoniae in infants from Sierra Leone.

Journal: Frontiers in microbiology

Published: March 03, 2026

Causes of mortality and severe morbidity in young children in Sierra Leone: a prospective cohort study.

Causes of mortality and severe morbidity in young children in Sierra Leone: a prospective cohort study.

Journal: The Lancet. Global health

Published: January 14, 2026

Prevalence of Molecular Markers of Resistance to Antimalarial Drugs Three Years After Perennial Malaria Chemoprevention in Sierra Leone.

Prevalence of Molecular Markers of Resistance to Antimalarial Drugs Three Years After Perennial Malaria Chemoprevention in Sierra Leone.

Journal: Gates open research

Published: September 27, 2025

Impact of oral azithromycin and intermittent preventive treatment with sulfadoxine-pyrimethamine regimen on child mortality in Sierra Leone: trial protocol for a randomised, two-arm, double-blinded, placebo-controlled clinical trial (ICARIA).

Impact of oral azithromycin and intermittent preventive treatment with sulfadoxine-pyrimethamine regimen on child mortality in Sierra Leone: trial protocol for a randomised, two-arm, double-blinded, placebo-controlled clinical trial (ICARIA).

Journal: Trials

Published: April 26, 2024

Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone.

Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone.

Journal: BMC public health

Published: October 19, 2023

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.

Journal: Vaccines

Published: July 01, 2023

Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone.

Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone.

Journal: Malaria journal

Published: February 01, 2023

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.

Journal: Emerging infectious diseases

Published: February 24, 2022

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.

Journal: The Lancet. Infectious diseases

Published: August 14, 2020

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.

Journal: The Lancet. Infectious diseases

Published: August 14, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026